Broad-spectrum kinome profiling identifies CDK6 upregulation as a driver of lenvatinib resistance in hepatocellular carcinoma
Carmen Oi Ning Leung(Hong Kong Polytechnic University), Terence K. Lee(Hong Kong Polytechnic University)
Cited by 47
Related Papers
Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
|Nature Reviews Gastroenterology & Hepatology|2021|472
EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma
|Cancer Research|2021|130
Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma
|Cancer Research|2022|106